| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00194305 |
| P698 | PubMed publication ID | 1535611 |
| P2093 | author name string | P S Harper | |
| P2860 | cites work | Huntington disease: genetics and epidemiology | Q24675741 |
| Linkage disequilibrium in Huntington's disease: an improved localisation for the gene | Q33593370 | ||
| Non-random association between alleles detected at D4S95 and D4S98 and the Huntington's disease gene | Q33593375 | ||
| Patterns of inheritance of the symptoms of Huntington's disease suggestive of an effect of genomic imprinting | Q33596722 | ||
| Huntington's disease in two New Britain families | Q33668004 | ||
| Huntington's chorea in South Wales: mutation, fertility, and genetic fitness | Q33670110 | ||
| A polymorphic DNA marker genetically linked to Huntington's disease | Q34255139 | ||
| Homozygotes for Huntington's disease | Q34559291 | ||
| Anticipation in myotonic dystrophy: new light on an old problem | Q35196194 | ||
| Huntington disease in Finland: linkage disequilibrium of chromosome 4 RFLP haplotypes and exclusion of a tight linkage between the disease and D4S43 locus | Q35197620 | ||
| The estimation of selection coefficients in Afrikaners: Huntington disease, porphyria variegata, and lipoid proteinosis | Q35197857 | ||
| Huntington disease in Maryland: clinical aspects of racial variation | Q35199222 | ||
| Huntington's chorea in Michigan. I. Demography and genetics | Q35911616 | ||
| Huntington's chorea in Michigan. 2. Selection and mutation. | Q35911685 | ||
| Mendelism in Relation to Disease | Q36100469 | ||
| Neurological disease in Uganda. | Q38899322 | ||
| Huntington's chorea. The basis for long-term prevention | Q39559939 | ||
| Investigations on Huntington's disease in the Canadian Prairies | Q39732071 | ||
| Genetic variation in Wales | Q39781031 | ||
| Natural history of Huntington's chorea | Q39809150 | ||
| Estimation of fertility and fitness in Huntington disease in New England | Q41232581 | ||
| Huntington's Chorea in South Wales. A genetic and epidemiological study | Q41472060 | ||
| The end in sight for Huntington disease? | Q43145917 | ||
| Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals | Q43411918 | ||
| Low prevalence of Huntington's disease in Finland | Q44003105 | ||
| Huntington's chorea in a South Australian comminity of aboriginal descent | Q44367467 | ||
| Huntington's chorea it India | Q44517934 | ||
| The high incidence of Huntington's chorea in the Duchy of Cornwall | Q45290088 | ||
| An educational approach to the social problem of Huntington's chorea. | Q45290186 | ||
| Observations on Huntington's chorea based on a Queensland survey. | Q45290394 | ||
| Epidemiological and linkage studies on Huntington's disease in Italy | Q45294390 | ||
| The prevalence of Huntington's disease in Tasmania | Q45294406 | ||
| Prevalence of Huntington's disease among UK immigrants from the Indian subcontinent | Q45294841 | ||
| Epidemiology of Huntington's disease in Rijeka district, Yugoslavia. | Q45295468 | ||
| The prevalence and patterns of care of Huntington's chorea in Grampian | Q45295888 | ||
| Huntington disease: no evidence for locus heterogeneity | Q45296111 | ||
| Huntington's chorea in Norway | Q45297482 | ||
| Huntington's chorea: a prevalence study in the Florence area | Q45298094 | ||
| Epidemiologic study of Huntington disease in the catchment area of the Würzburg University Neurologic Clinic with special reference to the Lower Franconia district | Q45298498 | ||
| Huntington disease in South African blacks. A report of 8 cases | Q45298815 | ||
| Population studies of Huntington's disease in Wales | Q45298834 | ||
| Huntington's disease mortality in the United States | Q45298842 | ||
| Huntington's chorea. Investigation into the prevalence of this disease in the area covered by the North East Metropolitan Regional Hospital Board | Q45301146 | ||
| Some problems in Huntington's chorea | Q45301197 | ||
| Prevalence and occurrence of some rare neurological diseases in Iceland | Q45301665 | ||
| Huntington's chorea in the West of Scotland | Q45301796 | ||
| Huntington's chorea in Bedfordshire, England. | Q45302424 | ||
| Huntington's chorea in Papua | Q45304337 | ||
| Possible introduction of Huntington's chorea into Pacific islands by New England whalemen | Q45304844 | ||
| Huntington's Chorea in the Netherlands The problem of genetic heterogeneity | Q45304848 | ||
| The prevalence of Huntington's chorea in South Africa | Q45306177 | ||
| The origin of Huntington's chorea in the Afrikaner population of South Africa | Q45306182 | ||
| Huntington's disease in black kindreds in South Carolina | Q45306550 | ||
| Huntington's Chorea in Northamptonshire | Q50418078 | ||
| Huntington's chorea in Northamptonshire. | Q55500816 | ||
| Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy | Q55670526 | ||
| Single-gene neurological disorders in South Wales: an epidemiological study | Q68060635 | ||
| Genetic imprinting in clinical genetics | Q68442586 | ||
| Huntington's chorea in Northamptonshire | Q73646874 | ||
| Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota | Q78383584 | ||
| Huntington's Chorea in the Moray Firth Area | Q78994176 | ||
| P433 | issue | 4 | |
| P921 | main subject | epidemiology | Q133805 |
| Huntington's disease | Q190564 | ||
| P304 | page(s) | 365-376 | |
| P577 | publication date | 1992-06-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Human Genetics | Q5937167 |
| P1476 | title | The epidemiology of Huntington's disease | |
| P478 | volume | 89 |
| Q90212067 | "It's being part of the big picture, even though you're a tiny jigsaw piece"-motivations and expectations of individuals participating in the Enroll-HD observational study |
| Q26824646 | 'The clocks that time us'--circadian rhythms in neurodegenerative disorders |
| Q45295068 | 11C-Diprenorphine Binding in Huntington's Disease: A Comparison of Region of Interest Analysis with Statistical Parametric Mapping |
| Q45301537 | A grand challenge: providing benefits of clinical genetics to those in need. |
| Q35753388 | A review of the treatment options for Huntington's disease |
| Q43131306 | A shared mechanism of muscle wasting in cancer and Huntington's disease. |
| Q33596076 | A study of the Huntington's disease associated trinucleotide repeat in the Scottish population. |
| Q36528887 | Advances in Huntington's disease diagnostics: development of a standard reference material |
| Q22305812 | Advances in the Pharmacological Management of Huntingtonʼs Disease |
| Q22306403 | An Unusually Low Prevalence of Huntington’s Disease in Iceland |
| Q30660685 | An overview of psychiatric symptoms in Huntington's disease |
| Q41002513 | Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study |
| Q38960290 | Avocado as a Major Dietary Source of Antioxidants and Its Preventive Role in Neurodegenerative Diseases |
| Q33836239 | Bioenergetics in Huntington's disease |
| Q33838303 | Body composition in premanifest Huntington's disease reveals lower bone density compared to controls |
| Q24554218 | Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease |
| Q28509836 | Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form |
| Q28732051 | Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study |
| Q34353562 | Chorea and its disorders |
| Q34346879 | Chorea and related disorders. |
| Q45304641 | Clinical and genetic characteristics in patients with Huntington’s Disease from Argentina |
| Q36078124 | Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington's disease in rats |
| Q43071425 | Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism |
| Q45289712 | Degeneration of the cerebellum in Huntington's disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. |
| Q77621138 | Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s |
| Q24514989 | Disease gene mapping in isolated human populations: the example of Finland |
| Q45304331 | Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. |
| Q45299719 | Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population |
| Q33949349 | Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death |
| Q45298405 | Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS). |
| Q38928751 | Faulty splicing and cytoskeleton abnormalities in Huntington's disease |
| Q45296975 | Founder mutation for Huntington disease in Caucasus Jews |
| Q35764318 | Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans |
| Q45288507 | Genetic association of Huntington's disease and restless legs syndrome? A family report |
| Q42722993 | HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia |
| Q58586047 | Hospitalizations of Children with Huntington's Disease in the United States |
| Q37718036 | How vital is sleep in Huntington's disease? |
| Q41628677 | Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA) |
| Q33255155 | Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families |
| Q39821493 | Huntington disease in County Donegal: epidemiological trends over four decades. |
| Q37186056 | Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes |
| Q82993834 | Huntington's Disease |
| Q35286098 | Huntington's Disease and Striatal Signaling. |
| Q47288617 | Huntington's Disease: Premotor Phase |
| Q34162629 | Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem |
| Q39193175 | Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. |
| Q42472433 | Huntington's disease and mitochondrial alterations: emphasis on experimental models |
| Q45296260 | Huntington's disease confirmed by genetic testing in five african families |
| Q44252850 | Huntington's disease in Greece: the experience of 14 years |
| Q43453337 | Huntington's disease: current epidemiology and pharmacological management in UK primary care. |
| Q35038660 | Huntington's disease: the mystery unfolds? |
| Q40612866 | Huntington's disease: update and review of neuropsychiatric aspects |
| Q35486706 | Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing |
| Q28079546 | Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review |
| Q33674159 | Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset |
| Q77525543 | Ionizing radiation and genetic risks IX. Estimates of the frequencies of mendelian diseases and spontaneous mutation rates in human populations: a 1998 perspective |
| Q35158376 | Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? |
| Q36048042 | Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype |
| Q33181735 | Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. |
| Q74790223 | Molecular Genetics of Huntington’s Disease |
| Q26775932 | Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges |
| Q35618345 | Neurotrophic factors in Huntington's disease |
| Q47687033 | Nonhuman Primate Models of Neurodegenerative Disorders |
| Q35016366 | Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report |
| Q34537760 | Palliative care for people with late-stage Huntington's disease |
| Q28263471 | Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review |
| Q28661435 | Plants and phytochemicals for Huntington's disease |
| Q35936394 | Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study |
| Q45299422 | Predictive and prenatal diagnosis of Huntington's disease: attitudes of Mexican neurologists, psychiatrists, and psychologists |
| Q39694466 | Projected numbers of people with movement disorders in the years 2030 and 2050. |
| Q38410393 | Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly |
| Q45294302 | Reduced penetrance of the Huntington's disease mutation |
| Q41979514 | Reliability of clinical diagnosis of Huntington's disease |
| Q37557789 | Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease |
| Q36799911 | Sleep deficits but no metabolic deficits in premanifest Huntington's disease |
| Q30416862 | Suicidal ideation in Huntington disease: the role of comorbidity |
| Q35435335 | Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium |
| Q34184185 | Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. |
| Q38663086 | The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers |
| Q24616907 | The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis |
| Q34680311 | The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test |
| Q34406943 | The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis. |
| Q41456204 | The genetic defect causing Huntington's disease: repeated in other contexts? |
| Q34411338 | Therapeutic approaches to preventing cell death in Huntington disease |
| Q41821958 | Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease |
| Q26782004 | Treatment of Huntington's disease |
| Q34381607 | Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European haplogroup a. |
| Q38109547 | Two Decades of Huntington Disease Testing: Patient's Demographics and Reproductive Choices |
| Q38812246 | Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature |
| Q35518978 | Young onset dementia |
Search more.